1. Home
  2. INGN vs PLX Comparison

INGN vs PLX Comparison

Compare INGN & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.57

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.39

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGN
PLX
Founded
2001
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
168.4M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
INGN
PLX
Price
$6.57
$2.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.25
$12.00
AVG Volume (30 Days)
221.8K
677.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
N/A
EPS
N/A
0.22
Revenue
$348,668,000.00
$52,744,000.00
Revenue This Year
$8.03
$36.81
Revenue Next Year
$7.76
N/A
P/E Ratio
N/A
$10.50
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$1.41
52 Week High
$9.13
$3.19

Technical Indicators

Market Signals
Indicator
INGN
PLX
Relative Strength Index (RSI) 50.51 60.49
Support Level $6.00 $2.06
Resistance Level $6.72 $2.42
Average True Range (ATR) 0.26 0.09
MACD -0.01 -0.00
Stochastic Oscillator 36.75 58.70

Price Performance

Historical Comparison
INGN
PLX

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: